[Effects of left heart function changes on cerebral small vessel diseases and its cognitive impairment]

W Zhao1, X Q Zhu, H Liu

  • 1Department of Neurology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.

Insights

Reduced left ventricular ejection fraction (LVEF) is linked to cognitive impairment in cerebral small vessel disease (CSVD). Lower LVEF independently predicts CSVD and its associated vascular cognitive impairment (VCI).

Area of Science:

  • Cardiology
  • Neurology
  • Geriatrics

Background:

  • Cerebral small vessel disease (CSVD) is a common cause of cognitive decline in the elderly.
  • Left heart dysfunction may contribute to the development and progression of CSVD and cognitive impairment.
  • Understanding the relationship between cardiac function and cognitive status in CSVD patients is crucial for effective management.

Purpose of the Study:

  • To investigate the association between alterations in left heart function and cognitive impairment in patients diagnosed with CSVD.
  • To identify specific echocardiographic parameters reflecting left heart function that correlate with cognitive deficits in CSVD.
  • To determine if impaired left heart function serves as an independent risk factor for CSVD and vascular cognitive impairment (VCI).

Main Methods:

  • A cohort of 199 CSVD patients and 103 healthy controls underwent neuroimaging (MRI) for CSVD markers and cognitive assessments (MMSE, CAMCOG-C).
  • Echocardiography was used to measure left ventricular ejection fraction (LVEF) and left atrial diameter (LAD).
  • Statistical analyses, including correlation and logistic regression, were employed to analyze the relationships between cardiac function, cognitive scores, and CSVD status.

Main Results:

  • CSVD patients exhibited significantly lower LVEF and higher LAD compared to healthy controls.
  • Patients with CSVD and vascular cognitive impairment (CSVD-VCI) showed significantly lower LVEF than those with CSVD but no cognitive impairment (CSVD-NCI).
  • LVEF positively correlated with cognitive function scores (MMSE, CAMCOG-C) and emerged as an independent risk factor for CSVD and CSVD-VCI.

Conclusions:

  • Changes in left heart function, particularly reduced LVEF, play a significant role in the pathogenesis of CSVD.
  • Declined LVEF is independently associated with the presence and severity of cognitive impairment in CSVD patients.
  • Left heart function assessment, specifically LVEF, is important for evaluating cognitive impairment risk in CSVD.

Related Concept Videos

Cognitive Dissonance01:38

Cognitive Dissonance

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
36.8K
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
632
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
267
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
480
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
315